FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1584436743> ?p ?o ?g. }

• W1584436743 endingPage "56" @default.
• W1584436743 startingPage "49" @default.
• W1584436743 abstract "Collagenase-isolated rat islets were labelled for 2 h in myo-[2-3H]inositol solution supplemented with 2.75 mM-glucose. The phorbol ester phorbol 12-myristate 13-acetate (PMA; 0.1 or 1 microM) was also present in some experiments. After labelling, islets were washed and then perifused in 2.75 mM-glucose to establish basal [3H]inositol-efflux and insulin-secretory rates. Subsequently, the responses of these islets to stimulation with various agonists were assessed. Inositol phosphate accumulation was measured at the termination of the perifusion. In separate experiments, the cellular location of protein kinase C (PKC) after PMA pretreatment was measured by quantitative immunoblotting of membrane and cytosolic fractions. The following observations were made. (1) Labelling in 0.1-1 microM-PMA had no deleterious effect on total [3H]inositol incorporation during the 2 h labelling period. However, islets labelled for 2 h in 1 microM-PMA were unable to respond, in terms of increases in insulin release, to a 1 microM-PMA stimulus during the subsequent perifusion. (2) As compared with the responses of control islets labelled in 2.75 mM-glucose alone, islets labelled in the additional presence of 1 microM-PMA displayed a significant impairment in phosphoinositide (PI) hydrolysis, but an enhancement of both first-and second-phase insulin secretion, in response to subsequent 20 mM-glucose stimulation. (3) Decreasing extracellular Ca2+ level to 0.1 mM and including the Ca(2+)-channel antagonist nitrendipine (0.5 microM) along with 1 microM-PMA during the [3H]inositol-labelling period did not alter the response of the islets to the subsequent addition of 20 mM-glucose. Glucose-induced PI hydrolysis was still inhibited and 20 mM-glucose-induced insulin release was still enhanced. (4) A markedly amplified and sustained insulin-secretory response to 200 microM-tolbutamide in the presence of 2.75 mM-glucose was also obtained from 1 microM-PMA-pretreated islets. This contrasts sharply with the small and transient response to tolbutamide noted in control islets. (5) When present only during the perifusion phase of the experiments, nitrendipine (0.5 microM) abolished the amplified insulin-secretory responses to both 20 mM-glucose and 200 microM-tolbutamide noted in PMA-pretreated islets. (6) Prior labelling in 1 microM-PMA dramatically amplified the insulinotropic effect of 25 mM-K+ or 5 microM-A23187 stimulation. The amplified insulin-secretory response to K+, but not to A23187, was abolished by inclusion of nitrendipine during the perifusion.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W1584436743 created "2016-06-24" @default.
• W1584436743 creator A5027891469 @default.
• W1584436743 creator A5037077908 @default.
• W1584436743 creator A5061989008 @default.
• W1584436743 creator A5071150333 @default.
• W1584436743 creator A5077735376 @default.
• W1584436743 date "1991-08-15" @default.
• W1584436743 modified "2023-09-27" @default.
• W1584436743 title "Effects of the phorbol ester phorbol 12-myristate 13-acetate (PMA) on islet-cell responsiveness" @default.
• W1584436743 cites W1220599151 @default.
• W1584436743 cites W1516614444 @default.
• W1584436743 cites W1549576466 @default.
• W1584436743 cites W1802980406 @default.
• W1584436743 cites W1910322155 @default.
• W1584436743 cites W1965005201 @default.
• W1584436743 cites W1966997010 @default.
• W1584436743 cites W1967259169 @default.
• W1584436743 cites W2006441560 @default.
• W1584436743 cites W2006575279 @default.
• W1584436743 cites W2015114102 @default.
• W1584436743 cites W2016362762 @default.
• W1584436743 cites W2036225322 @default.
• W1584436743 cites W2057736378 @default.
• W1584436743 cites W2072862748 @default.
• W1584436743 cites W2082866489 @default.
• W1584436743 cites W2092406361 @default.
• W1584436743 cites W2095475365 @default.
• W1584436743 cites W2096308603 @default.
• W1584436743 cites W2123315947 @default.
• W1584436743 cites W2136189765 @default.
• W1584436743 cites W2139547269 @default.
• W1584436743 cites W2157865424 @default.
• W1584436743 cites W2328575328 @default.
• W1584436743 cites W2328734100 @default.
• W1584436743 cites W2414940966 @default.
• W1584436743 cites W2438237435 @default.
• W1584436743 doi "https://doi.org/10.1042/bj2780049" @default.
• W1584436743 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1151447" @default.
• W1584436743 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1652943" @default.
• W1584436743 hasPublicationYear "1991" @default.
• W1584436743 type Work @default.
• W1584436743 sameAs 1584436743 @default.
• W1584436743 citedByCount "24" @default.
• W1584436743 countsByYear W15844367432014 @default.
• W1584436743 countsByYear W15844367432022 @default.
• W1584436743 crossrefType "journal-article" @default.
• W1584436743 hasAuthorship W1584436743A5027891469 @default.
• W1584436743 hasAuthorship W1584436743A5037077908 @default.
• W1584436743 hasAuthorship W1584436743A5061989008 @default.
• W1584436743 hasAuthorship W1584436743A5071150333 @default.
• W1584436743 hasAuthorship W1584436743A5077735376 @default.
• W1584436743 hasBestOaLocation W15844367432 @default.
• W1584436743 hasConcept C126322002 @default.
• W1584436743 hasConcept C134018914 @default.
• W1584436743 hasConcept C165220095 @default.
• W1584436743 hasConcept C170493617 @default.
• W1584436743 hasConcept C181199279 @default.
• W1584436743 hasConcept C185592680 @default.
• W1584436743 hasConcept C195794163 @default.
• W1584436743 hasConcept C24998067 @default.
• W1584436743 hasConcept C2777427919 @default.
• W1584436743 hasConcept C2778618036 @default.
• W1584436743 hasConcept C2779306644 @default.
• W1584436743 hasConcept C2780043322 @default.
• W1584436743 hasConcept C2780548744 @default.
• W1584436743 hasConcept C2909761558 @default.
• W1584436743 hasConcept C519063684 @default.
• W1584436743 hasConcept C55493867 @default.
• W1584436743 hasConcept C71924100 @default.
• W1584436743 hasConcept C86803240 @default.
• W1584436743 hasConceptScore W1584436743C126322002 @default.
• W1584436743 hasConceptScore W1584436743C134018914 @default.
• W1584436743 hasConceptScore W1584436743C165220095 @default.
• W1584436743 hasConceptScore W1584436743C170493617 @default.
• W1584436743 hasConceptScore W1584436743C181199279 @default.
• W1584436743 hasConceptScore W1584436743C185592680 @default.
• W1584436743 hasConceptScore W1584436743C195794163 @default.
• W1584436743 hasConceptScore W1584436743C24998067 @default.
• W1584436743 hasConceptScore W1584436743C2777427919 @default.
• W1584436743 hasConceptScore W1584436743C2778618036 @default.
• W1584436743 hasConceptScore W1584436743C2779306644 @default.
• W1584436743 hasConceptScore W1584436743C2780043322 @default.
• W1584436743 hasConceptScore W1584436743C2780548744 @default.
• W1584436743 hasConceptScore W1584436743C2909761558 @default.
• W1584436743 hasConceptScore W1584436743C519063684 @default.
• W1584436743 hasConceptScore W1584436743C55493867 @default.
• W1584436743 hasConceptScore W1584436743C71924100 @default.
• W1584436743 hasConceptScore W1584436743C86803240 @default.
• W1584436743 hasIssue "1" @default.
• W1584436743 hasLocation W15844367431 @default.
• W1584436743 hasLocation W15844367432 @default.
• W1584436743 hasLocation W15844367433 @default.
• W1584436743 hasLocation W15844367434 @default.
• W1584436743 hasOpenAccess W1584436743 @default.
• W1584436743 hasPrimaryLocation W15844367431 @default.
• W1584436743 hasRelatedWork W1584436743 @default.
• W1584436743 hasRelatedWork W1850629359 @default.

• next